MedPath

Remifentanil and Atropine for Intubation in Neonates

Phase 4
Completed
Conditions
Endotracheal Intubation
Interventions
Drug: Atropine/Remifentanil
Drug: Fentanyl/Atropine/Succinylcholine
Registration Number
NCT00815048
Lead Sponsor
King Saud University
Brief Summary

The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Hemodynamically stable neonates of any gestational age admitted to the Neonatal Intensive Care Unit at McMaster Children's Hospital requiring an elective endotracheal intubation was anticipated.
Exclusion Criteria
  • Urgent intubations
  • Cyanotic congenital heart lesions
  • Anticipated difficult airway
  • Concurrent or recently administered (within 3 hours of the procedure) intravenous opioid infusions
  • Pre-existing hyperkalemia
  • Family history of malignant hyperthermia
  • Prior enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RemifentanilAtropine/RemifentanilAtropine Remifentanil
FentanylFentanyl/Atropine/SuccinylcholineAtropine Fentanyl Succinylcholine
Primary Outcome Measures
NameTimeMethod
Time to Successful intubation15 minutes
Secondary Outcome Measures
NameTimeMethod
Time to return of spontaneous respirations15 minutes
Oxygen saturationDuring the procedure up to 15 minutes
Heart RateDuring the procedure up to 15 minutes
Blood PressureDuring the procedure up to 15 minutes
Intubation Condition15 minutes post procedure
Evidence of Trauma15 minutes post procedure

Trial Locations

Locations (1)

McMaster University NICU

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath